Mefloquine effectively prevents malaria during pregnancy but is not well tolerated

April 05, 2018

Pregnant women are particularly vulnerable to malaria infections, which can have severe consequences on their health and that of their babies.

For this reason, it is recommended that pregnant women living in malaria-endemic areas take preventive measures including an antimalarial treatment. Sulphadoxine-pyrimethamine (SP) is the currently used treatment but drug-resistant parasites have started to emerge. Furthermore, SP is not recommended in HIV-infected women that take the prophylactic antibiotic cotrimoxazole due to possible drug interactions. Therefore, there is an urgent need to find alternative drugs to prevent malaria in pregnant women, and one such drug could be mefloquine.

ISGlobal researchers performed a systematic review in literature to determine if mefloquine is effective and safe in preventing malaria during pregnancy, both among HIV-negative and HIV-positive women. They identified 5 studies in sub-Saharan Africa and one in Thailand (a total of more than 8,000 women) that compared mefloquine with currently used drugs to prevent malaria in pregnant women. The results show that, compared with SP or cotrimoxaxole alone, mefloquine is more effective in reducing parasite levels in the mothers' blood as well as anemia at the time of delivery. However, the drug is less well tolerated (there was a higher risk of adverse events including vomiting, fatigue and dizziness).

"These conclusions are in agreement with a review previously published by our group", explains lead author. "The efficacy of mefloquine is well established, but its low tolerability represents a big obstacle to its widespread use in these particularly vulnerable populations. We now need to find alternative drugs that have the same antimalarial effect but without the adverse events", adds the ISGlobal researcher.
-end-


Barcelona Institute for Global Health (ISGlobal)

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.